9/18/2008

The Czech National Bank allowed Sanofi-Aventis to extend its takeover offer for Zentiva, a generic-drug firm, until Nov. 28. The petition came after Zentiva CEO Jiri Michal said Sanofi's $1.8 billion bid was too low and asked shareholders to reject the proposal.

Full Story:
Bloomberg

Related Summaries